Electrophoretic profile of serum proteins in opium and heroin dependents

American Journal of Drug and Alcohol Abuse

Volumn 34, Issue 6, 2008, Pages 769-773

  Divsalar, Kouros ^a   Meymandi, Manzumeh Shamsi ^a,b   Saravani, Ramin ^c   Zarandi, Minoo Mahmoudi ^d   Shaikh Al Eslami, Azar ^d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dependency; Electrophoresis; Iran; Opioid

Indexed keywords

ALBUMIN; ALPHA 1 GLOBULIN; ALPHA 2 GLOBULIN; ALPHA GLOBULIN; BETA GLOBULIN; DIAMORPHINE; GLOBULIN; IMMUNOGLOBULIN; OPIATE; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; HEROIN DEPENDENCE; HUMAN; INFECTION RISK; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OPIATE ADDICTION; PROTEIN ELECTROPHORESIS;

ALPHA-GLOBULINS; BETA-GLOBULINS; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS; FEMALE; GAMMA-GLOBULINS; HEROIN DEPENDENCE; HUMANS; MALE; OPIOID-RELATED DISORDERS; SERUM ALBUMIN; SERUM GLOBULINS;

EID: 56549111412     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990802406686     Document Type: Article

References (23)

1. UNODC. World drug report, UNODC 2006. New York: United Nations Publication, 2006.
2. Friedman H, Eisenstein TK. Neurological basis of drug dependence and its effects on the immune system. J Neuroimmunol 2004; 147(1-2):106-108.
3. Kosten T, Owens SM. Immunotherapy for the treatment of drug abuse. Pharmacol Ther 2005; 108(1):76-85.
4. Burtis CA, Edward R, Ashwood B. Tietz Fundementals of Clinical Chemistry. 5 ed. Philadelphia: W B, Saunders Company, 2001.
5. Katzung B. Basic and Clinical Pharmacology. New York: Lang Medical Books/McGraw-Hill, 2001.
6. Howard B, Hud A. Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG. (editors). Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill, 2001.
7. Olsen GD. Morphine binding to human plasma proteins. Clin Pharmacol Ther 1975; 17(1):31-35.
8. Nagamatsu K, Ohno Y, Ikebuchi H, Takahashi A, Terao T, Takanaka A. Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. Biochem Pharmacol 1986; 35(20):3543-3548.
9. Gomez-Lechon MJ, Ponsoda X, Jover R, Fabra R, Trullenque R, Castell JV. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes. Mol Toxicol 1987; 1(4):453-463.
10. Banerjee D, Sarkar NK. A study of hepatobiliary function in chronic heroin smokers. Addict Biol 1996; 1(2):197-200.
11. Ringle DA, Herndon BL. Immunologic effects of morphine administration in rabbits. J Immunol 1975; 115(3):876-883.
12. Walker MC, Simon EJ. The purification of antimorphine antibodies by affinity chromatography. J Pharmacol Exp Ther 1977; 203(2):360-364.
13. Beranek JT, De Cato L, Adler FL. Binding of morphine by serum globulins from morphine-treated rabbits. I. Induction and measurement of binding. Int Arch Allergy Appl Immunol 1976; 51(3):298-310.
14. Li L, Zhao WZ, Yang SQ, Fu N, Xu JP. Preparation and characterization of antimorphine antiserum. Di Yi Jun Yi Da Xue Xue Bao. The second round name. 2004; 24(6):673-676.
15. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 2001; 62(2):111-123.
16. Allolio B, Schulte HM, Deuss U, Kallabis D, Hamel E, Winkelman W. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol (Copenh) 1987; 114(4):509-514.
17. Roy S, Wang J, Gupta S, Charboneau R, Loh HH, Barke RA. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet. J Neuroimmunol 2004; 147(1-2):78-81.
18. Rezaei Poor R ASAS, Nayarin HA. The effects of addiction on phagocytosis and cellular immunity. Journal of the Faculty of Paramedical Sciences 2003; 3(1):141-149.
19. Rezai Poor R EN, Salehi M, Nikbin B. Effects of addiction on humoral immunity. Journal of Medical Council of Islamic Rpublic of Iran 2003; 4(21):271-275.
20. Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16(2):209-219.
21. Bangsberg DR, Rosen JI, Aragon T, Campbell A, Weir L, Perdreau-Remington F. Clostridial myonecrosis cluster among injection drug users: A molecular epidemiology investigation. Arch Intern Med 2002; 162(5):517-522.
22. Battjes RJ, Leukefeld CG, Pickens RW, Haverkos HW. The acquired immunodeficiency syndrome and intravenous drug abuse. Bull Narc 1988; 40(1):21-34.
23. Ramos V, Castro MA, de la Iglesia F, Martinez MM, Juega J, Sanchez P, et al. Immunoglobulins, beta-2 microglobulin and lymphocyte subpopulations in patients addicted to parenteral drugs (IVDA). An Med Interna 1992; 9(11):538-542.